Patricia  Jumbo Lucioni
Associate Professor
McWhorter School of Pharmacy
Department of Pharmaceutical, Social and Administrative Sciences
2220 CHS Building 2
pjumbolu@samford.edu
205-726-4170

After completing medical training in Lima, Peru, Patricia Jumbo-Lucioni earned a PhD in Nutrition Sciences from the University of Alabama at Birmingham in 2009, specializing in the genetics of complex traits and mitochondrial physiology using Drosophila melanogaster as model system. She furthered her expertise in fly genetics and neurodevelopmental deficits during her postdoctoral training at Emory and Vanderbilt University. She joined Samford University in 2016. Her research explores the therapeutic potential of ACE inhibitors and microbiome-targeted interventions in mitigating behavioral deficits and metabolic dysfunction in a Drosophila melanogaster (fruit fly) model of aging and Alzheimer’s disease.

Degrees and Certifications

  • MD, Universidad Peruana Cayetano Heredia
  • PhD, nutrition sciences, University of Alabama at Birmingham
  • Certificate of College Teaching, Vanderbilt University

Awards and Honors

  • AACP Biological Section-Excellence in Teaching Award, American Association of Colleges of Pharmacy, 2023

  • 2022 Carl Storm Underrepresented Minority (CSURM) Fellowship, Gordon Research Conferences, 2022

  • Abstract acceptance at the 2022 Angiotensin Gordon Research Conference, Gordon Research Conferences, 2022

  • 2022 Scholar Award, Samford University McWhorter School of Pharmacy

Publications

Involvement

  • Alabama Academy of Science, Member
  • Alzheimer’s Association, Member.
  • Alzheimer’s Association-Alabama Chapter, Community Educator
  • American Association of Colleges of Pharmacy, Biological Sciences section member

Expertise

Metabolic and mitochondrial physiology, neurodegenerative diseases, Drosophila husbandry and genetics

Research Areas

  • Pharmacological interventions in Alzheimer’s disease
  • Behavioral and molecular characterization of neurodegenerative models
  • Gut-brain axis as a therapeutic target for cognitive impairment
  • Innovations in pharmacy education to enhance research engagement